Biohaven (BHVN) Other Operating Expenses (2022 - 2025)

Biohaven (BHVN) reported Other Operating Expenses of $109.9 million for Q4 2025, down 35.08% sequentially from $169.4 million in Q2 2025.

Biohaven (BHVN) Other Operating Expenses (2022 - 2025) Analysis & Trends

Biohaven (BHVN) has 2 years of Other Operating Expenses data on file, last reported at $109.9 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Biohaven	2.13 Bn	1.78 Bn	-

Download Data